Soliman Nahed A, Morsia Deaa Fekri, Helmy Noha A H
Department of Pathology, Faculty of Medicine, Helwan University, Helwan 11795, Egypt.
Department of Pathology, Faculty of Medicine, University of Mansoura, Mansoura 35516, Egypt.
Open Access Maced J Med Sci. 2019 May 27;7(10):1608-1617. doi: 10.3889/oamjms.2019.357. eCollection 2019 May 31.
Microsatellite instability (MSI) is the genetic pathway underlying 15% of sporadic colorectal carcinoma (CRC) and hereditary non-polyposis CRC. MSI-H CRC has a distinct clinicopathological characteristic including excess mucin and signet ring component, proximal colon, Crohn's like reaction, lymphocytic infiltration, and better survival.
This research aims to screen Egyptian CRC patients for MSI status by IHC testing of expression of the MMR proteins in correlation to its clinicopathological features.
Immunohistochemistry study for mismatch repair proteins (MMR) was done on 115 cases of CRC. Their expressions were assessed and correlated to clinicopathological parameters in an attempt to obtain the most significant predictors of MSI.
MSI (low and high) represents 67% of the study cases. The most frequent expression pattern was combined loss of MLH, and PMS2 (38% of MSI) followed by a combined loss of MSH2, and MSH6 (29% of MSI). There was significant correlation of expression pattern of MMR proteins with the laterality, lymphovascular emboli, perineural invasion, grade, T stage, N stage, signet ring component, tumor infiltrating lymphocyte, and peritumoral lesion (0.014, 0.035, 0.012, 0.033, 0.013, 0.000, 0.041, 0.012, and 0.009 respectively). Proximal location (right sided) and lower grade, higher nodal stage, and marked TIL were selected as predictors of MS-H CRC (0.005, 0.031, 0.025, and 0.000 respectively).
All clinicopathological and histological parameters should be assessed in CRC for the sake of predicting MSI. The optimal approach to MSI evaluation is (IHC) assessment of MMR proteins.
微卫星不稳定性(MSI)是15%的散发性结直肠癌(CRC)和遗传性非息肉病性结直肠癌的遗传途径。MSI-H CRC具有独特的临床病理特征,包括黏液过多和印戒细胞成分、近端结肠、克罗恩样反应、淋巴细胞浸润以及较好的生存率。
本研究旨在通过免疫组化检测错配修复(MMR)蛋白的表达情况及其与临床病理特征的相关性,对埃及CRC患者的MSI状态进行筛查。
对115例CRC病例进行错配修复蛋白(MMR)的免疫组化研究。评估其表达情况,并将其与临床病理参数相关联,以试图获得MSI的最显著预测指标。
MSI(低和高)占研究病例的67%。最常见的表达模式是MLH和PMS2联合缺失(占MSI的38%),其次是MSH2和MSH6联合缺失(占MSI的29%)。MMR蛋白的表达模式与肿瘤侧别、淋巴管栓子、神经周围浸润、分级、T分期、N分期、印戒细胞成分、肿瘤浸润淋巴细胞和瘤周病变显著相关(分别为0.014、0.035、0.012、0.033、0.013、0.000、0.041、0.012和0.009)。近端部位(右侧)、低分级、高淋巴结分期和显著的肿瘤浸润淋巴细胞被选为MS-H CRC的预测指标(分别为0.005、0.031、0.025和0.000)。
为了预测MSI,应对CRC的所有临床病理和组织学参数进行评估。MSI评估的最佳方法是对MMR蛋白进行免疫组化(IHC)评估。